Thrombocytopenia in patients with chronic liver disease is reportedly caused by decreased TPO production in the diseased liver, accelerated platelet destruction due to splenomegaly accompanying portal hypertension, decreased hematopoietic capacity of the bone marrow [14, 15] and autoantibody production in the spleen. Here, TPO is linked to portal hypertension.